Kunkalla, M
Typical Anthem prior authorization requirements for weight loss GLP-1 medications include a BMI of 30 or above, or a BMI of 27 or above with at least one qualifying weight-related comorbidity such as hypertension, type 2 diabetes, dyslipidemia, or obstructive sleep apnea
Because IGF-1 LR3 is not clinically approved, safety data in humans is limited
In nutrient-replete states, GLP-1induced insulin signaling suppresses adipose lipolysis, whereas during reduced caloric intake and relative glucose scarcity, lipid substrates become the dominant oxidative fuel [59, 60]
Heavy alcohol use works against your recovery, sleep, and results, so moderation matters
however, there are known differences between semaglutide, dulaglutide, liraglutide and exenatide in the magnitude of these effects